Please login to the form below
inflammatory diseases
This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
Human Cell Atlas gets new UK funding
Researchers say insights gained from the atlas could help to increase understanding of diseases such as asthma and cancer develop and progress, or point to new diagnostic tools and treatments. ... Creating a highly detailed atlas of the skin. A spotlight
-
Mallinckrodt doses first patient in muscular dystrophy trial
Mallinckrodt has kicked off a phase II trial of its Duchenne muscular dystrophy candidate, a repurposed drug used for years for inflammatory and autoimmune diseases. ... Current formulations of the drug is used to treat inflammatory bowel disease,
-
Sangamo bulks up in cell therapy with TxCell acquisition
in solid organ transplant patients and with follow-up projects in other autoimmune diseases and inflammatory such as Crohn’s disease and multiple sclerosis. ... generation autologous and allogeneic CAR-Treg cell therapies for use in treating autoimmune
-
GSK sells eczema and psoriasis drug to Dermavant for £250m
And with the latter now going, its position in inflammatory diseases is looking increasingly truncated.
-
Morning brief: New biotech launched, Merck and Moderna expand collaboration and more
Autophagy-focused Casma Therapeutics launched with $58.5m fund. Casma Therapeutics, a new biotech company focused on unlocking the process of autophagy to tackle a wide range of diseases has been ... Preclinical data suggest this could lead to treatments
More from news
Approximately 5 fully matching, plus 117 partially matching documents found.
Latest Intelligence
-
‘How is your day?’
Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP
-
The tipping point
In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.
-
Taking a lean and careful approach
Its fully human engineered CD3 antibody Foralumab has reached phase II with potential for a wide range of autoimmune and inflammatory diseases such as non-alcoholic steatohepatitis (NASH), primary biliary cholangitis, ... Database of diseases. The
-
Grünenthal's relentless pursuit of relief
It is a good fit strategically for us because it enriches our portfolio in the area of inflammatory and pain-related diseases with high unmet need. ... Pain has nervous and inflammatory components and we are interested in everything around the
-
Deal Watch December 2016
510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences
He has 30 years’experience in research and development specifically in gastrointestinal disorders, inflammatory diseases and cancers, and previously co-founded Synergy Pharmaceuticals and served as its chief scientific officer.
-
Kymab appoints its first chief medical officer
She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
-
Dr Li Zhou joins TxCell as cell engineering VP
Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
-
Vedanta Biosciences appoints two new heads
Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.
-
Lorin Johnson joins Atlantic Healthcare board
Atlantic's lead asset, alicaforsen for the treatment of the inflammatory bowel diseases ulcerative colitis and pouchitis.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Infographic: Spondyloarthritis
Infographic: Spondyloarthritis. Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic
-
Infographic: Spondyloarthritis
Infographic: Spondyloarthritis. Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Featured jobs
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Sudler London - Senior Medical Writer
-
Competitive
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Account Manager
-
Negotiable
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Medical Writer
-
Salary is DOE
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Account Director or Senior Account Director
-
Salary TBC
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
Subscribe to our email news alerts
- Moving annual total (MAT)
- Key success factor (KSF)
- AZ prepares to file COPD triple, taking on rival GSK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Gilead targets hep B in half a billion dollar deal with Precision BioSciences
- Teva wins FDA OK for crucial migraine drug
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
